206 related articles for article (PubMed ID: 23907566)
21. Adjuvant therapy for locally advanced gastric cancer.
Aoyama T; Yoshikawa T
Surg Today; 2017 Nov; 47(11):1295-1302. PubMed ID: 28251375
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy for gastric cancer: what have we learned since INT0116?
Jácome AA; Sankarankutty AK; dos Santos JS
World J Gastroenterol; 2015 Apr; 21(13):3850-9. PubMed ID: 25852269
[TBL] [Abstract][Full Text] [Related]
23. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
[TBL] [Abstract][Full Text] [Related]
24. Surgical and combined treatment of gastric cancer--own experience.
Berner J; Tenderenda M; Pasz S; Berner A; Piekarski J
Przegl Lek; 2000; 57 Suppl 5():14-5. PubMed ID: 11202279
[TBL] [Abstract][Full Text] [Related]
25. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
27. Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Aoyama T; Yoshikawa T; Watanabe T; Hayashi T; Ogata T; Cho H; Tsuburaya A
Gastric Cancer; 2011 Aug; 14(3):274-8. PubMed ID: 21461654
[TBL] [Abstract][Full Text] [Related]
28. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
29. Significance of palliative gastrectomy for late-stage gastric cancer patients.
Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
31. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
32. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
33. Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.
Scartozzi M; Pistelli M; Bittoni A; Giampieri R; Galizia E; Berardi R; Faloppi L; Del Prete M; Cascinu S
Curr Oncol Rep; 2010 May; 12(3):175-85. PubMed ID: 20425077
[TBL] [Abstract][Full Text] [Related]
34. Palliative gastrectomy and chemotherapy for stage IV gastric cancer.
Lin SZ; Tong HF; You T; Yu YJ; Wu WJ; Chen C; Zhang W; Ye B; Li CM; Zhen ZQ; Xu JR; Zhou JL
J Cancer Res Clin Oncol; 2008 Feb; 134(2):187-92. PubMed ID: 17611776
[TBL] [Abstract][Full Text] [Related]
35. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy].
Du C; Guo C; Xu Q; Wang J; Zhou A
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):622-7. PubMed ID: 26714605
[TBL] [Abstract][Full Text] [Related]
37. Perspectives of surgery and multimodality treatment in gastric carcinoma.
Meyer HJ; Jähne J; Wilke H
J Cancer Res Clin Oncol; 1993; 119(7):384-94. PubMed ID: 8491758
[TBL] [Abstract][Full Text] [Related]
38. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
40. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
